Product Images Zonisade

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Zonisade NDC 52652-8001 by Azurity Phramaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

carton-label-061722 - zonisamide oral suspension carton label

carton-label-061722 - zonisamide oral suspension carton label

This is a medication called ZONISADE™, which comes in a 150 mL bottle as an oral suspension containing 100 mg/5mL of the active ingredient onisanie (zonisamide). The recommended dosage is not provided, and the document advises to keep all medications out of the reach of children. Additionally, it provides storage instructions, suggests shaking well before use, and includes a note to pharmacists about dispensing medication guides for patients. The medication is made by Aautty Pramaceutical, Inc. in Wilmington, MA, USA, and the bottle label also includes a logo for azurity®.*

Chemical Structure - zonisamide oral suspension chemical stucture

Chemical Structure - zonisamide oral suspension chemical stucture

container-label-061722 - zonisamide oral suspension container label

container-label-061722 - zonisamide oral suspension container label

Zonisade™ is an oral suspension medication which contains 20mg of zonisamide per mL. The recommended dosage should be obtained from the prescribing information. Zonisade™ should be kept out of reach of children and stored between 20°C and 25°C. Once opened, any unused portion should be discarded after 30 days. A medication guide is available at zonisade.com/medication-guide.pdf. This medication is manufactured in the United Kingdom for Azurity® in Wilmington, USA. The lot number and expiration date are provided, and a dispensing label should be affixed.*

Figure 1 - zonisamide oral suspension figure 1

Figure 1 - zonisamide oral suspension figure 1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.